and other low-sugar or sugar-free products. Other zero- or low-calorie sweeteners that are natural like stevia, monk fruit extract, and many others are FDA-approved but they aren’t considered ...
Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies ...
In accepting the FDA’s motion, U.S. District Judge Mark Pittman put on hold a lawsuit filed by the Outsourcing Facilities ...
The approval is also significant for a host of other 'complex generic' products in the US, with the FDA announcing measures to reduce barriers to their approval. Shares in Teva ticked down on the ...
If the FDA agrees with DSM-Firmenich's request, the next step will be for the FDA to propose adding bemotrizinol to the list of over-the ... "Consumers are purchasing products with bemotrizinol ...
(INDV) announced that the U.S. Food and Drug Administration has granted Priority Review designation for the Prior Approval Supplement of ... means that the FDA's goal is to take action on an ...
Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...
today announced that the U.S. Food and Drug Administration (the "FDA") has approved the Company's Prior Approval Supplement Application for ZYNRELEF® (bupivacaine and meloxicam) extended-release ...
On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...
Heron Therapeutics, Inc., a commercial-stage biotechnology company, announced that the US Food and Drug Administration (FDA) has approved the company's Prior Approval Supplement Application for ...